Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Akifumi Onishi"'
Autor:
Keiko Tanaka, Hitoshi Sugiyama, Hiroshi Morinaga, Akifumi Onishi, Katsuyuki Tanabe, Haruhito A. Uchida, Hiroki Maruyama, Jun Wada
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
Fabry disease (FD) is an X-linked disorder resulting in a deficiency of α-galactosidase A (GLA) activity. The R112H mutation of GLA is relatively common in Japanese FD patients, characterized by a late-onset phenotype, almost normal to mild lyso-Gb3
Externí odkaz:
https://doaj.org/article/dc24f115485b46959a505e0bd122c687
Autor:
Hiroki Maruyama, Atsumi Taguchi, Mariko Mikame, Atsushi Izawa, Naoki Morito, Kazufumi Izaki, Toshiyuki Seto, Akifumi Onishi, Hitoshi Sugiyama, Norio Sakai, Kenji Yamabe, Yukio Yokoyama, Satoshi Yamashita, Hiroshi Satoh, Shigeru Toyoda, Michihiro Hosojima, Yumi Ito, Ryushi Tazawa, Satoshi Ishii
Publikováno v:
Current Issues in Molecular Biology, Vol 43, Iss 1, Pp 389-404 (2021)
Fabry disease is an X-linked disorder of α-galactosidase A (GLA) deficiency. Our previous interim analysis (1 July 2014 to 31 December 2015) revealed plasma globotriaosylsphingosine as a promising primary screening biomarker for Fabry disease proban
Externí odkaz:
https://doaj.org/article/b772c007d4b741eca470f621bcdfd666
Autor:
Keiko Tanaka, Masashi Kitagawa, Akifumi Onishi, Toshio Yamanari, Ayu Ogawa-Akiyama, Koki Mise, Tatsuyuki Inoue, Hiroshi Morinaga, Haruhito A. Uchida, Hitoshi Sugiyama, Jun Wada
Publikováno v:
Kidney & Blood Pressure Research, Vol 42, Iss 2, Pp 284-293 (2017)
Background/Aims: Bleeding is the most common complication after renal biopsy. Although numerous predictors of bleeding have been reported, it remains unclear whether arterial stiffness affects bleeding complications. Method: We performed an observati
Externí odkaz:
https://doaj.org/article/a70602b6136b4c1f81c20a66b3ad4c01
Autor:
Ayu Ogawa-Akiyama, Hitoshi Sugiyama, Masashi Kitagawa, Keiko Tanaka, Akifumi Onishi, Toshio Yamanari, Hiroshi Morinaga, Haruhito Adam Uchida, Kazufumi Nakamura, Hiroshi Ito, Jun Wada
Publikováno v:
PLoS ONE, Vol 13, Iss 3, p e0193695 (2018)
Cystatin C is a cysteine protease inhibitor that is produced by nearly all human cells. The serum level of cystatin C is a stronger predictor of the renal outcome and the risk of cardiovascular events than the creatinine level. The resistive index (R
Externí odkaz:
https://doaj.org/article/1f18fcebbcb74592b8a70f306f0dcb60
Autor:
Keiko Tanaka, Hitoshi Sugiyama, Hiroshi Morinaga, Akifumi Onishi, Yuzuki Kano, Hidemi Takeuchi, Kenji Tsuji, Motoki Kubo, Katsuyuki Tanabe, Haruhito A. Uchida, Kazufumi Nakamura, Jun Wada
Publikováno v:
Annals of Internal Medicine: Clinical Cases. 2
Autor:
Mariko Mikame, Kenji Yamabe, Hiroshi Satoh, Toshiyuki Seto, Shigeru Toyoda, Hiroki Maruyama, Hitoshi Sugiyama, Norio Sakai, Akifumi Onishi, Michihiro Hosojima, Naoki Morito, Yukio Yokoyama, Satoshi Yamashita, Atsushi Izawa, Kazufumi Izaki, Satoshi Ishii, Atsumi Taguchi, Ryushi Tazawa, Yumi Ito
Publikováno v:
Current Issues in Molecular Biology
Volume 43
Issue 1
Pages 32-404
Current Issues in Molecular Biology, Vol 43, Iss 32, Pp 389-404 (2021)
Volume 43
Issue 1
Pages 32-404
Current Issues in Molecular Biology, Vol 43, Iss 32, Pp 389-404 (2021)
Fabry disease is an X-linked disorder of α-galactosidase A (GLA) deficiency. Our previous interim analysis (1 July 2014 to 31 December 2015) revealed plasma globotriaosylsphingosine as a promising primary screening biomarker for Fabry disease proban
Autor:
Katsuyuki Tanabe, Masashi Kitagawa, Koki Mise, Yuzuki Kano, Haruhito A. Uchida, Keiko Tanaka, Hiroshi Morinaga, Ayu Ogawa-Akiyama, Hitoshi Sugiyama, Jun Wada, Akifumi Onishi, Toshio Yamanari, Masaru Kinomura
Publikováno v:
Disease Markers, Vol 2019 (2019)
Disease Markers
Disease Markers
Background. Alterations in DNA methylation may be involved in disease progression in patients with chronic kidney disease (CKD). Recent studies have suggested that 5-methyl-2′-deoxycytidine (5MedC) may be a marker of hypermethylation of DNA. Curren
Autor:
Hiroki Maruyama, Satoshi Ishii, Masaru Shimura, Takeshi Inoue, Mariko Mikame, Gaku Matsukura, Tsuyoshi Shiga, Kenichiro Hanawa, Ryushi Tazawa, Atsumi Taguchi, Mimiko Matsumura, Mio Ebato, Jun Kajihara, Ichijiro Murata, Saori Yamamoto, Satoshi Yamashita, Hitoshi Sugiyama, Kei Murayama, Kaori Miyata, Teiko Sakai, Koichi Tamita, Chu Guili, Toshihiro Kawasaki, Shigeru Toyoda, Hiroshi Satoh, Koichiro Sugimura, Takamasa Oda, Akifumi Onishi, Shigehisa Ura, Takeo Fujimura, Hideki Takano
Publikováno v:
Genetics in Medicine
Purpose Plasma globotriaosylsphingosine (lyso-Gb3) is a promising secondary screening biomarker for Fabry disease. Here, we examined its applicability as a primary screening biomarker for classic and late-onset Fabry disease in males and females. Met
Autor:
Ayu Ogawa-Akiyama, Jun Wada, Masashi Kitagawa, Keiko Tanaka, Toshio Yamanari, Katsuyuki Tanabe, Hitoshi Sugiyama, Akifumi Onishi, Kenichi Shikata, Yasukazu Ohmoto, Jun Eguchi, Koki Mise, Hiroshi Morinaga
Publikováno v:
Nephrology. 23:855-862
Aim Trefoil factor 3 (TFF3) is a small peptide that is involved in mucosal protection. TFF3 is widely expressed in multiple tissues including kidney tissue. Previous studies have reported that the levels of urinary TFF3 are significantly increased in
Autor:
Tatsuyuki Inoue, Hiroshi Morinaga, Ayu Ogawa-Akiyama, Jun Wada, Hitoshi Sugiyama, Keiko Tanaka, Haruhito A. Uchida, Toshio Yamanari, Koki Mise, Masashi Kitagawa, Akifumi Onishi
Publikováno v:
Kidney & Blood Pressure Research, Vol 42, Iss 2, Pp 284-293 (2017)
Background/Aims: Bleeding is the most common complication after renal biopsy. Although numerous predictors of bleeding have been reported, it remains unclear whether arterial stiffness affects bleeding complications. Method: We performed an observati